Novel method of neuroprotection by pharmacological inhibition of AMPactivated protein kinase

Details for Australian Patent Application No. 2005226731 (hide)

Owner Fasgen, LLC Johns Hopkins University

Inventors Li, Hong; McFadden, Jill; McCullough, Louise D.; Ronnett, Gabriele V.

Agent Wrays

Pub. Number AU-A-2005226731

PCT Pub. Number WO2005/092068

Priority 60/556,000 24.03.04 US

Filing date 23 March 2005

Wipo publication date 6 October 2005

International Classifications

A61K 31/00 (2006.01)

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092068 Priority application(s): WO2005/092068

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005226736-Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation

2005226729-Imidazole compounds